S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 8, 2010
April 24, 2020
5b838cf4-2c2e-4c10-8a24-439ce4ce61f1
Related Documents
Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry
Guidance DocumentDecember 2, 2019Center for Drug Evaluation and Research
E17 General Principles for Planning and Design of Multi-Regional Clinical Trials
Guidance DocumentJuly 19, 2018Center for Drug Evaluation and Research
Labeling for Biosimilar Products Guidance for Industry
Guidance DocumentJuly 18, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.